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Background
A prolonged QT is a major risk factor for developing
Torsades de Pointes, a potentially fatal cardiac dysrhyth-
mia. The prolongation of QT interval may be due to
adverse drug reactions. Many drugs such as haloperidol
and methadone are known to prolong the QT interval.
In effect, it is one of the most common reasons for drug
withdrawal from the market [1]. Here, we propose to
identify drugs that may promote QT prolongation using
electronic medical records.
Materials and methods
As an ongoing effort in studying drug effects, Vanderbilt
University Medical Center has constructed an anon-
ymized database of medication orders and ECGs of all
inpatients admitted for 2 to 30 days from 1999 to 2003.
QT prolongations were detected from cardiologist-gen-
erated, free-text ECG impressions by combining nega-
tion detection and the natural language processor,
KnowledgeMap concept identifier (KMCI) [2]. From this
dataset, we designed our study to identify potential
drugs that promote QT prolongations as their side
effects by examining medications taken prior to the
events. For instance, when QT prolongation is detected
for a patient, drugs administered 72 hours prior are
retrieved for further analysis. To determine which drug
is more likely to be associated with the QT prolonga-
tion, we applied the chi-square (Χ
2) statistic.
Results
With a predefined level of significance at 0.001 (i.e. Χ
2 ≥
10.827), 8 drugs showed significant signals, table 1.
Among them, 3 drugs have FDA-approved labels of QT
prolongation as their known actions [3].
False positive predictions may be due to the fact that
our study was based on hospitalized patients with acute
diseases. Those patients may be taking a long list of
medications and some drugs may interact with each
other to contribute to the outcome.
Conclusions
The preliminary results showed that we are able to use
inpatient medical records to detect drugs known to pro-
long QT intervals. For future study, it is crucial to con-
sider patient existing conditions, health history, and
contributions of other medications.
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Table 1 Potential drugs that prolong QT interval with
significance level of 0.001
Drug Chi-square Evidence
Amiodarone 39.21 Known reaction
Potassium
supplements
24.78 Treatment – typically given to people
with long QT intervals to keep it normal
Procainamide 22.11 Known reaction
Sotalol 21.62 Known reaction
Warfarin 18.42 No evidence found
Meperidine 18.13 No evidence found
Oxycodone 17.08 No evidence found
Promethazine 12.90 No evidence found
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